TMA64 Antibody

What is TMA64 and what is its role in protein translation?

TMA64 is the yeast homologue of eukaryotic initiation factor 2D (eIF2D), a protein involved in translation regulation. Research has established that TMA64 primarily functions in recycling 40S ribosomal subunits after translation termination. It operates at stop codons following Rli1/ABCE1-catalyzed dissociation of 60S subunits and prevents inappropriate translation reinitiation . This recycling function is critical for maintaining proper translation termination and preventing ribosomes from reinitiating at downstream AUG codons, particularly in 3'UTRs .

What cellular processes is TMA64 involved in?

TMA64 functions primarily in translation termination and ribosome recycling pathways. Specifically, it prevents 40S ribosomal subunits from inappropriately reinitiating translation after reaching stop codons . Ribosome profiling studies have shown that when TMA64 is absent (along with its functional partners TMA20 and TMA22), ribosomes can stall at stop codons and unrecycled 40S subunits may reinitiate translation at AUG codons in the 3'UTR . Additionally, TMA64 exhibits strong ribosome anti-association activity, preventing the premature reassociation of 60S subunits with post-termination 40S subunits .

What structural domains characterize the TMA64 protein?

TMA64 contains a SUI1 (eIF1) domain at its C-terminus that adopts a similar fold to eIF1 and binds at the same location as eIF1 on the platform of the 40S ribosomal subunit . The N-terminal portion of TMA64/eIF2D binds below the 40S platform and makes contact with the CCA tail of tRNA . This interaction does not appear to be specific to the methionyl moiety, suggesting it may not be limited to initiator tRNA . These structural features enable TMA64 to interact with ribosomes and potentially prevent binding of canonical initiation factors like eIF2 to recycled 40S subunits .

How does TMA64 function with binding partners in ribosome recycling?

TMA64 appears to work redundantly with the complex formed by TMA20 (MCT-1) and TMA22 (DENR) in recycling 40S ribosomal subunits . This functional redundancy is supported by observed negative genetic interactions between the TMA20 and TMA64 genes . Studies typically examine double deletion strains (tma64Δ/tma20Δ and tma64Δ/tma22Δ) to control for this redundancy . All three proteins contain SUI1 domains that bind at similar locations on the 40S subunit, suggesting a shared mechanism of action in preventing 40S subunits from engaging in inappropriate reinitiation events .

What phenotypes are associated with TMA64 deletion or mutation?

• 80S ribosomes queued behind stop codons, consistent with a block in 40S recycling

• Increased ribosome density in 3'UTRs, particularly at AUG codons

• Evidence of translation reinitiation at these 3'UTR AUG codons

Reporter analyses confirm these findings, showing production of peptides initiated from 3'UTR AUG codons in tma mutant strains . These observations collectively indicate that TMA64 and its partners play crucial roles in preventing inappropriate translation events after termination.

How does TMA64 contribute to preventing reinitiation after translation termination?

TMA64, along with TMA20 and TMA22, prevents reinitiation through several mechanisms:

• The binding site of TMA64 on the 40S ribosome overlaps with canonical initiation factors like eIF1 and eIF2, likely preventing their recruitment to post-termination 40S complexes

• TMA64/eIF2D occupies positions where inter-subunit bridges form with the 60S subunit, accounting for its strong ribosome anti-association activity

• By preventing both canonical initiation factor binding and 60S reassociation, TMA64 effectively blocks two potential reinitiation pathways:

  • 40S scanning and reinitiation at downstream AUG codons

  • 80S ribosome-mediated reinitiation

Ribosome profiling provides strong evidence for this model, showing increased 3'UTR translation at AUG codons in tma deletion strains .

What experimental evidence supports TMA64's role in ribosome recycling?

Multiple experimental approaches provide evidence for TMA64's role in ribosome recycling:

• Ribosome profiling: tma deletion strains show 80S ribosomes queued behind stop codons, consistent with a recycling defect

• Increased 3'UTR translation: A comparison of ribosome density in 3'UTRs versus ORFs revealed increased 3'UTR density in tma mutants across most genes, suggesting unrecycled 40S subunits reinitiate translation downstream

• AUG-centered peaks: Density peaks appear at 3'UTR AUG codons specifically in tma deletion strains

• Reporter constructs: Myc-tagged reporter constructs inserted downstream of 3'UTR AUG codons confirmed translation of these regions in tma mutants

• AUG mutation studies: Mutation of these AUG codons reduced expression of the reinitiation products, confirming the mechanism

These complementary approaches firmly establish TMA64's function in preventing post-termination translation events.

How does TMA64 interact with the ribosome at the molecular level?

Structural studies including cryo-EM and crystal structures have revealed:

• The SUI1 domain of TMA64/eIF2D adopts a similar fold to eIF1 and binds at the same location on the 40S subunit platform

• TMA64/eIF2D binds to the ribosome at positions where inter-subunit bridges normally form with the 60S subunit

• The N-terminal part of TMA64/eIF2D binds below the 40S platform and contacts the CCA tail of tRNA

• This interaction with tRNA does not involve the methionyl moiety, suggesting it may interact with both initiator and elongator tRNAs

• The binding sites overlap with canonical initiation factors like eIF1 and eIF2, explaining the mechanism of preventing reinitiation

These molecular interactions underpin TMA64's ability to prevent reassociation of 60S subunits and recruitment of canonical initiation factors to post-termination 40S complexes.

How should researchers validate a TMA64 antibody before experimental use?

For comprehensive validation of a TMA64 antibody, researchers should follow this sequential approach:

• Initial reactivity testing: Verify antibody binding to the immunogen, but recognize that this alone is insufficient for validation

• Recombinant protein verification: Test antibody reactivity with cells overexpressing TMA64 or with purified recombinant TMA64 protein

• Endogenous protein detection: This critical step requires:

  • Testing in at least two positive and two negative control samples (cells/tissues)

  • Confirming positivity/negativity based on transcript expression data

  • Demonstrating that the antibody does not bind in the absence of TMA64

• Genetic validation: For definitive confirmation, compare antibody reactivity in:

  • Wild-type versus TMA64 knockout (tma64Δ) samples

  • Samples with and without siRNA-mediated TMA64 knockdown

Following this comprehensive protocol ensures that the antibody specifically recognizes TMA64 under experimental conditions.

What controls are essential when using TMA64 antibodies in immunoblotting?

When performing Western blots with TMA64 antibodies, include these essential controls:

These controls collectively ensure reliable and specific detection of TMA64 while minimizing the risk of false positive or negative results .

What experimental approaches can verify TMA64 antibody specificity?

To comprehensively verify TMA64 antibody specificity, implement multiple complementary approaches:

• Genetic verification:

  • Compare reactivity in wild-type versus TMA64 knockout (tma64Δ) samples

  • Use RNA interference to knockdown TMA64 and observe corresponding signal reduction

• Epitope competition:

  • Pre-incubate antibody with immunizing peptide/protein

  • Signal should be significantly reduced if binding is specific

• Multiple antibody verification:

  • Use independent antibodies targeting different TMA64 epitopes

  • Consistent results across antibodies increase confidence in specificity

• Molecular weight verification:

  • Confirm that detected band(s) match the predicted molecular weight of TMA64

  • Consider potential post-translational modifications

• Mass spectrometry:

  • Immunoprecipitate with TMA64 antibody and identify pulled-down proteins

  • TMA64 should be among the most abundant proteins identified

These approaches provide complementary evidence for antibody specificity, increasing confidence in experimental results.

How can researchers distinguish between TMA64 and its homologs in immunological assays?

To ensure specific detection of TMA64 versus related proteins:

• Epitope selection: Choose antibodies raised against unique regions of TMA64 that don't share sequence homology with TMA20, TMA22, or other translation factors

• Multiple antibody approach: Use multiple antibodies targeting different TMA64 epitopes to confirm results

• Genetic controls: Compare reactivity in:

  • Wild-type samples

  • TMA64 knockout/knockdown samples

  • TMA20 or TMA22 knockout/knockdown samples
    This approach helps determine whether the antibody cross-reacts with homologs

• Size discrimination: Use predicted molecular weights to distinguish TMA64 from related proteins on Western blots

• Reciprocal immunoprecipitation: Perform pull-downs with antibodies against TMA64 and its binding partners to assess cross-reactivity

These strategies help ensure that observed signals genuinely represent TMA64 rather than its homologs or binding partners.

What are common issues when detecting TMA64 in Western blots?

Researchers may encounter several challenges when detecting TMA64 via Western blotting:

Understanding these common issues and their solutions can significantly improve the reliability of TMA64 detection in experimental settings.

How can researchers optimize immunoprecipitation experiments with TMA64 antibodies?

For successful TMA64 immunoprecipitation experiments:

• Lysis optimization:

  • Use buffers that preserve native protein conformation

  • Consider that TMA64 interacts with ribosomes and RNA , which may affect extraction

  • Include RNase treatment controls to determine if RNA affects antibody binding

• Antibody selection and coupling:

  • Choose antibodies validated for immunoprecipitation applications

  • Test different coupling approaches (direct coupling, protein A/G beads)

  • Determine optimal antibody-to-lysate ratios empirically

• Co-factor considerations:

  • TMA64 interacts with ribosomal components and potentially TMA20/TMA22

  • Adjust salt and detergent concentrations based on whether you want to:

    • Preserve interactions (milder conditions)

    • Study TMA64 alone (more stringent conditions)

• Controls:

  • Include IgG control immunoprecipitations

  • Perform parallel immunoprecipitations from TMA64-negative samples

  • Consider reciprocal immunoprecipitations with antibodies against known interactors

Following these guidelines will improve the specificity and efficiency of TMA64 immunoprecipitation experiments.

What factors might affect TMA64 antibody performance across different experimental systems?

When using TMA64 antibodies across different experimental systems, consider these potential variables:

• Expression level variations:

  • TMA64/eIF2D expression may vary between cell types or growth conditions

  • Verify expression at the transcript level before antibody experiments

• Epitope accessibility differences:

  • TMA64's interactions with ribosomes, tRNA, and other factors may mask epitopes

  • These interactions may differ between systems, affecting antibody binding

• Post-translational modifications:

  • If TMA64 undergoes cell-type specific modifications, epitope recognition could be affected

  • Consider using multiple antibodies targeting different regions

• Experimental condition differences:

  • Buffer compositions, detergents, or fixation methods may affect epitope availability

  • Standardize protocols when comparing across systems

• Homolog expression:

  • Expression levels of TMA20/TMA22 or other related proteins may vary

  • This could affect interpretation if antibody has any cross-reactivity

Understanding these variables helps researchers interpret differences observed across experimental systems.

What methods can detect endogenous TMA64 in fixed cells or tissues?

For detecting endogenous TMA64 in fixed samples:

• Fixation optimization:

  • Test different fixation methods (paraformaldehyde, methanol, acetone)

  • Consider gentle fixation to preserve epitope accessibility

  • Implement antigen retrieval methods if necessary

• Antibody validation for immunostaining:

  • Verify antibody works in fixed samples using positive controls

  • Include negative controls (TMA64-depleted samples if available)

  • Use appropriate dilution ranges (starting with 1:50-1:500 for IHC applications)

• Signal amplification options:

  • Consider tyramide signal amplification for low-abundance detection

  • Evaluate different detection systems (fluorescent vs. chromogenic)

  • Use confocal microscopy to improve signal-to-noise ratio

• Controls and verification:

  • Use siRNA knockdown or genetic knockout controls where possible

  • Confirm specificity with peptide competition experiments

  • Correlate staining patterns with known subcellular localization of TMA64

These approaches help ensure reliable detection of endogenous TMA64 in fixed biological samples while minimizing background and non-specific signals.

How should researchers interpret TMA64 signal variations across different cell types?

When analyzing TMA64 expression patterns across different cell types or tissues:

• Establish baseline expression:

  • Determine TMA64 expression levels in reference cell types using quantitative Western blotting

  • Correlate protein levels with mRNA expression data where available

  • Consider that ribosome-associated proteins may show expression proportional to translation activity

• Systematic analysis approach:

  • Standardize protein loading and detection methods across all samples

  • Quantify TMA64 signals relative to housekeeping proteins

  • Present data as fold-changes relative to a reference cell type

• Physiological context interpretation:

  • Higher TMA64 levels may correlate with increased translational activity

  • Consider developmental stage, differentiation status, and metabolic state

  • Interpret in light of TMA20/TMA22 levels due to their functional redundancy

• Verification methods:

  • Confirm unusual expression patterns with multiple antibodies

  • Validate protein expression with mRNA analysis

  • Consider functional assays to determine if expression differences correlate with translation recycling efficiency

This systematic approach helps distinguish biological variations from technical artifacts when comparing TMA64 levels across different cellular contexts.

What are the implications of altered TMA64 levels on translation and cellular function?

Based on TMA64's established role in ribosome recycling, alterations in its expression levels may have significant consequences:

Understanding these implications helps researchers interpret the functional consequences of TMA64 expression changes in various physiological and pathological contexts.

How can researchers determine if a TMA64 antibody is detecting the correct isoform?

To verify isoform-specific detection of TMA64:

• Isoform identification:

  • Analyze genomic databases to identify potential TMA64/eIF2D isoforms or splice variants

  • Determine which regions/epitopes differ between isoforms

• Molecular weight analysis:

  • Compare observed molecular weights on Western blots with predicted sizes of known isoforms

  • Use high-resolution gels to separate closely migrating isoforms

• Isoform-specific detection strategies:

  • Use antibodies targeting isoform-specific regions

  • Employ RT-PCR with isoform-specific primers to correlate mRNA with protein detection

  • Consider mass spectrometry to identify peptides unique to specific isoforms

• Verification using genetic approaches:

  • Express individual recombinant isoforms and compare migration patterns

  • Use isoform-specific knockdown/knockout strategies to confirm antibody specificity